Compare · HCAT vs NBIS
HCAT vs NBIS
Side-by-side comparison of Health Catalyst Inc (HCAT) and Nebius Group N.V. (NBIS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HCAT and NBIS operate in Computer Software: Programming Data Processing (Technology), so they compete in similar markets.
- NBIS is the larger of the two at $57.84B, about 405.6x HCAT ($142.6M).
- Over the past year, HCAT is down 54.3% and NBIS is up 346.4% - NBIS leads by 400.7 points.
- NBIS has been more active in the news (13 items in the past 4 weeks vs 11 for HCAT).
- HCAT has more recent analyst coverage (25 ratings vs 16 for NBIS).
PerformanceHCAT-54.32%NBIS+346.36%
2025-06-09+0.00%2026-06-08
- Company
- Health Catalyst Inc
- Nebius Group N.V.
- Price
- $1.91-1.30%
- $234.60+2.94%
- Market cap
- $142.6M
- $57.84B
- 1M return
- +19.44%
- +27.01%
- 1Y return
- -54.32%
- +346.36%
- Industry
- Computer Software: Programming Data Processing
- Computer Software: Programming Data Processing
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2019
- 2011
- News (4w)
- 11
- 13
- Recent ratings
- 25
- 16
HCAT
Health Catalyst Inc
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its solutions include a cloud-based data platform, analytics software, and professional services. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. The company was founded in 2008 and is headquartered in South Jordan, Utah.
Latest HCAT
- Med-Metrix Enters Into Definitive Agreement to Acquire Vitalware to Enhance Coding Accuracy and Net Revenue Yield
- Health Catalyst Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
- Health Catalyst to Divest Vitalware for $147 Million, Accelerating Strategic Transformation
- CEO Albert Benjamin covered exercise/tax liability with 336 shares, decreasing direct ownership by 0.02% to 1,458,456 units (SEC Form 4) to satisfy withholding obligation
- Chief People Officer Llewelyn Linda covered exercise/tax liability with 8,519 shares, decreasing direct ownership by 3% to 321,132 units (SEC Form 4) to cover taxes
- Chief Financial Officer Alger Jason covered exercise/tax liability with 18,804 shares, decreasing direct ownership by 3% to 722,840 units (SEC Form 4) (for withholding tax)
- General Counsel Landry Benjamin covered exercise/tax liability with 13,779 shares, decreasing direct ownership by 4% to 364,539 units (SEC Form 4) (tax liability)
- Director Larson-Green Julie was granted 12,710 shares, increasing direct ownership by 16% to 94,644 units (SEC Form 4)
- SEC Form DEFA14A filed by Health Catalyst Inc
- SEC Form DEF 14A filed by Health Catalyst Inc
Latest NBIS
- Nebius chooses Kao Data's Harlow campus for major AI infrastructure deployment
- Nebius expands in UK with more NVIDIA-powered infrastructure, more customers, and more cloud capabilities for agentic and enterprise AI
- Chief Technology Officer Shtan Danila sold $3,746,448 worth of Class A Shares (15,678 units at $238.96) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 291,700 units (SEC Form 4)
- Chief Revenue Officer Boroditsky Marc sold $2,976,333 worth of Class A Shares (10,776 units at $276.20), decreasing direct ownership by 29% to 26,886 units (SEC Form 4) to cover withholding tax
- CFO Alonso Sanchez Maria Del Dado sold $416,786 worth of Class A Shares (1,509 units at $276.20), decreasing direct ownership by 11% to 12,672 units (SEC Form 4) (tax liability)
- BNP Paribas Exane initiated coverage on Nebius Group N.V. with a new price target
- Nebius to present at BofA Global Technology conference
- Amendment: SEC Form 20-F/A filed by Nebius Group N.V.
- General Counsel Tal Boaz sold $1,016,905 worth of Class A Shares (5,100 units at $199.39) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 80,754 units (SEC Form 4)
- Nebius and Bloom Energy partner to power AI infrastructure build-out